ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2%
Fri, 1 Nov

ALEMBIC PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m11,2719,48912,40930.8%10.1%
Other incomeRs m24334-89.0%-84.8%
TurnoverRs m11,2949,52212,41230.4%9.9%
ExpensesRs m8,2477,2408,95423.7%8.6%
Gross profitRs m3,0231,9643,45576.0%14.3%
DepreciationRs m2863543601.6%25.6%
InterestRs m58507142.0%21.8%
Profit before taxRs m2,7031,5933,02990.1%12.1%
TaxRs m70336052545.9%-25.3%
Profit after taxRs m2,0001,2332,504103.0%25.2%
Gross profit margin%26.820.727.8
Effective tax rate%26.022.617.3
Net profit margin%17.713.020.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 10.1% on a year-on-year (YoY) basis. The expenses were up by 8.6% YoY during the same period.
  • The company's operating profit increased by 14.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 2QFY20 as against 26.8% in 2QFY19.
  • Depreciation charges increased by 25.6% and finance costs increased by 21.8% YoY, respectively.
  • Other income declined by 84.8% YoY during the quarter.
  • Net profit for the quarter increased by 25.2% YoY. Net profit margins during the quarter increased from 17.7% in 2QFY19 to 20.2% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 30.8% on a quarter-on-quarter (QoQ) basis. The expenses were up by 23.7% QoQ during the same period.
  • The company's operating profit increased by 76.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 2QFY20 as against 20.7% in 1QFY19.
  • Net profit for the quarter increased by 103.0% QoQ, while net profit margins increased from 12.9% in 1QFY19 to 20.2% in 2QFY20.

To see how ALEMBIC PHARMA has performed over the last eight quarters,please visit here.

Access Now: Eight Steps to Your Eight Figure Fortune

ALEMBIC PHARMA Share Price Performance

Over the last one year,ALEMBIC PHARMA share price has moved down from Rs 601.6 to Rs 561.0, registering a Loss of Rs 40.6 or around 6.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,342.2 (up 0.9%). Over the last one year it has moved down from 14,632.9 to 13,342.2, a gain of 1,291 points (down 8.8%).

Overall, the S&P BSE SENSEX is up 16.6% over the year.

Current Valuations

At the current price of Rs 561.0, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 15.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.9 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2%". Click here!

  

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 24, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - DISHMAN PHARMA COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS